Trevor Baglin works in Vascular Medicine affiliated with Cambridge University Hospitals NHS Foundation Trust.
Trevor Baglin is the Global Head of Hemophilia at Centessa Pharmaceuticals. He previously served as a Consultant Haematologist at Cambridge University Hospitals NHS Foundation Trust from 1990 to 2016. He has published research on venous thromboembolism, blood coagulation, and antithrombotic therapies.
357 pubs · 18,520 cites · h-index 69
MB ChB
University of Manchester
PhD
University of Birmingham
MedScD
University of Cambridge
Global Head of Hemophilia
Centessa Pharmaceuticals
Venture Advisor
Medicxi
Consultant Haematologist
Cambridge University Hospitals NHS Foundation Trust · 1990 - 2016